Role of Endogenous Benzodiazepine Ligands and Their GABA-A-Associated Receptors in Hepatic Encephalopathy

By Ahboucha Samir   Butterworth Roger  

Metabolic Brain Disease, Vol. 20, Iss. 4, 2005-12 ,pp. : 425-437

Springer Publishing Company

Access to resources Recommend Favorite

Pathophysiology and management of hepatic encephalopathy 2014 update: Ammonia toxicity and hyponatremia

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 12, 2015-12 ,pp. : 1155-1162

John Wiley & Sons Inc

Access to resources Recommend Favorite

MEDICARE FROM THE STANDPOINT OF THE PHYSICIAN AND THE PATIENT IN NEW JERSEY*

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 15, Iss. 11, 1967-11 ,pp. : 979-983

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased Brain Concentrations of Endogenous (Non-benzodiazepine) GABA-A Receptor Ligands in Human Hepatic Encephalopathy

By Ahboucha Samir   Pomier-Layrargues Gilles   Butterworth Roger F.  

Metabolic Brain Disease, Vol. 19, Iss. 3-4, 2004-12 ,pp. : 241-251

Springer Publishing Company

Access to resources Recommend Favorite

Recovery from Parkinson Syndrome and Prolonged Visually Evoked Potentials in Hepatic Encephalopathy

By Finsterer Josef   Bernauer Elisabeth  

Metabolic Brain Disease, Vol. 20, Iss. 1, 2005-03 ,pp. : 55-60

Springer Publishing Company

Access to resources Recommend Favorite